Opioid Use clinical trials

Explore recruiting opioid use clinical trials.

Recruiting opioid use studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Opioid Use trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD)

Cyprus

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults with Opioid Use Disorder (Opioid Dependence)

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Single-Blind, Fixed-Order Crossover Study to Assess the Effects of CSX-1004 Injection on Fentanyl-Induced Respiratory Depression in Healthy Adult Subjects and Subjects with Opioid Use Disorder

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

(ROAR) Reversal of opioid-induced respiratory depression with opioid antagonists - a pharmacokinetic pharmacodynamic modeling study in opioid naïve individuals and chronic opioid users under real-life conditions

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Pilot study on the safety and feasibility of intravenous opioid agonist therapy (OAT) with Hydagelan® (hydromorphone hydrochloride) in Vienna.

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Opioid Use trials by city

Opioid Use in Toronto Opioid Use in Vancouver Opioid Use in Montreal Opioid Use in Calgary Opioid Use in Edmonton Opioid Use in Ottawa Opioid Use in Winnipeg Opioid Use in Quebec City Opioid Use in Hamilton Opioid Use in Kitchener Opioid Use in London Opioid Use in Halifax Opioid Use in New York Opioid Use in Los Angeles Opioid Use in Chicago Opioid Use in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease